Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials.
Zhang R, Hou QC, Li BH, Deng L, Yang YM, Li TX, Yao XQ, Yang LL, Lin XL, Liao YQ, Wang L, Liu YP, Tan J, Wan ZW, Shuai P.
Zhang R, et al. Among authors: wan zw.
Front Endocrinol (Lausanne). 2023 Jun 26;14:1132004. doi: 10.3389/fendo.2023.1132004. eCollection 2023.
Front Endocrinol (Lausanne). 2023.
PMID: 37455913
Free PMC article.